PubVisualPubVisual Book a Demo
Resources Blog About Contact Book a 30-Minute Demo →

Years of research. Millions invested. Skimmed in ten seconds.

Your science deserves to perform.

PubVisual turns approved publications into interactive experiences each physician explores their own way. Personal, interactive, and trusted, all built from one approved core.

Now exploring:

Scroll
PubVisual by RedNovius

Trusted by teams at leading pharma & biotech

Pfizer Roche Novartis AstraZeneca Amgen Johnson & Johnson Bayer Takeda Sanofi Bristol Myers Squibb Moderna Biogen Regeneron Genentech
The problem

Published is not the same as understood.

0%1

of the time, physicians read only the abstract. The rest of your publication goes unseen.

0%2

of healthcare professionals are now unreachable through conventional digital outreach.

0vs03

82% of pharma teams believe their outreach works. Only 28% of physicians agree.

1. Cross-sectional study of physician literature habits, LAU Medical Center (peer-reviewed).  2. HCP Access research.  3. State of HCP Engagement report.

The science is not the problem.
The delivery is.

The platform

One approved story. Every physician’s way in.

Three products, one approved core. Start where your science needs it most.

Personalize
PubVisual Smart Pathways

Makes it personal.

One publication becomes an adaptive journey for each physician, shaped by their specialty, their interest, and how deep they want to go. The cardiologist gets the outcomes. The scientist gets the mechanism. Nobody gets a PDF.

Explore Smart Pathways →
Dr. Elena RossiDr. Elena Rossiwants the mechanismKOL Cardiologist
MOA overview
Disease pathway
Biological rationale
Subgroup analysis
Requested the full publication
Dr. James MillerDr. James Millerwants the outcomesClinical Cardiologist
Primary endpoint
Key outcomes
Patient type fit
Dosing & titration
Booked 15 minutes with an MSL

The same approved study, explored two different ways, ending in two different actions.

Interact
PubVisual Engage

Makes it interactive.

Approved interactive moments appear right where attention peaks. Physicians question the data and act on it, without ever leaving the experience.

Explore Engage →
Approved next steps, matched to what they explore
Request the full publication
Explore the safety data
Answer a knowledge check
Recommended
Take it further
Pick a time that suits you
Meeting bookedWed 14:00

Interest becomes a booked conversation.

Amplify
PubVisual KOL

Makes it trusted.

We record the experts and build their commentary into the PubVisual itself. Physicians hear a respected peer speak on the science, and explore it in their own time.

Explore PubVisual KOL →
An expert-led film, built from one approved story.
Wherever your science lives

Oncology. Rare disease. Cardiology. We’ve likely already mapped it.

Bring us your therapeutic area and we bring the pattern that already works there: which routes physicians take, which questions come up, which format lands. You bring the publication and the context. We do the heavy lifting.

Oncology
Non-small cell lung cancerMultiple myelomaBreast cancer
Rare disease
ALSDuchenne muscular dystrophyFabry disease
Cardiology
Heart failureAtrial fibrillation
Immunology
PsoriasisRheumatoid arthritis
Neurology
Multiple sclerosisAlzheimer’s disease
Respiratory
COPDSevere asthma
Hematology
HemophiliaSickle cell disease
Endocrinology
Type 2 diabetesObesity

Not on the wall? Bring it anyway. The pattern travels; the therapeutic area is just where we start.

The process
One review.

You approve the core the normal way, at script, storyboard, and final animation. That same approved core then carries every version across new markets and languages, without restarting the scientific review, and the overall pace tracks your own review, which we plan around with you.

01
The publication drops

We start from your approved paper, poster, or data readout.

02
Storyboard, claims mapped

Every claim carries a footnote and an approved reference before a single frame is animated.

03
Into your MLR and Veeva review

Modular, version-controlled, and structured for review inside your existing Veeva workflow.

04
In the field

Live on HCP portals, in approved email, at congress, and in your MSLs’ hands.

Built for pharma reality. It runs inside your existing workflows and your existing review process.

The proof

“The first format my MSLs say physicians actually finish.”

Medical Affairs Lead
30+

languages from one approved core, produced without restarting the scientific review.

1

MLR review covers every journey a physician can take, not one review per route.

0

new claims created. Every frame maps back to the approved source.

Where it shows up

Live at the congresses that matter.

The same interactive science works the booth, the symposium screen, and the follow-up, at the meetings where your physicians already are.

ASCO ESMO ASH ESC AHA EULAR ECTRIMS ERS ATS ADA DDW

And it keeps working after the meeting: on HCP portals, in approved email, and in your MSLs’ hands.

Book a demo

See your science perform.

30 minutes. One real example from your therapeutic area. No slide deck.

Book a 30-Minute Demo →
Personal to every physician Interactive from the first frame Trusted voices behind the science
Questions

Frequently asked questions

PubVisual turns static pharmaceutical science, publications, MOAs, trial data, into interactive experiences physicians watch, explore, and remember. PubVisual has three products: Smart Pathways (adaptive journeys personalized to each physician), Engage (the interactive layer that turns interest into action), and KOL (expert-led engagement). PubVisual is a product of RedNovius.

Smart Pathways personalizes the journey, adapting the same approved story to each physician’s specialty and interest. Engage adds approved interactive moments so physicians can question the data and act on it. KOL puts the voices of trusted experts behind the science. They share one approved core, so they work on their own or together.

Yes. Everything is built for MLR from the first frame: modular, version-controlled, and structured for review inside your existing Veeva workflow.

It moves through your review, not around it. You approve the core the normal way, at script, storyboard, and final animation. From there, that same approved core carries every version, so new markets and languages do not restart the scientific review. The overall pace tracks your own review, which we plan around with you.

A video plays once and ends. We reimagine the science as something physicians can interrogate, with every claim mapped to an approved reference and the next step built in.